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ABSTRACT
Mannose and Lipopolysaccharide Receptors on the Surface of Granular Hemocytes from the
Crayfish Procambarus clarkii
by
Gelu Dobrescu
Procambarus clarkii hemocytes have been shown to bind to both LPS and a mannose containing
neoglycoprotein conjugated to fluorescent probes. A decrease in the observed number of
fluorescent hemocytes indirectly indicated that the binding of FITC-LPS to these cells is
impaired by initial incubation with LPS. Prior treatment of hemocytes with horseradish
peroxidase, a mannose rich glycoprotein, decreased their capacity to bind mannose. Mannan had
no inhibitory effect on the binding of either ligand. Mixed hemocytes and hemocyte
subpopulations separated by buoyant density were incubated with both ligands and revealed that
a subpopulation of granular hemocytes bound both LPS and mannose. These results suggest the
possible presence of 2 different pattern recognition cell surface receptors on this subpopulation
of granular hemocytes from the red swamp crayfish, Procambarus clarkii, which may
specifically recognize and bind to both LPS from gram-negative bacteria and to mannose
containing glycoproteins found on microbial surfaces.
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DEDICATION
I dedicate this work to the splendid and complex underlying principle of molecular
recognition that is involved in the discrimination between “self” and “non-self” by the immune
responses of all living organisms, and to the molecular conflict and/or symbiosis that occur
following recognition. Let us remember that for various reasons the distinction between “self”
and “non-self” can and sometimes does become blurry, but that conflict need not remain a
constant of life.
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CHAPTER 1
INTRODUCTION

Cellular and humoral pattern recognition molecules of vertebrates and invertebrates
initiate several kinds of innate defense mechanisms after specific recognition of
lipopolysaccharides (LPS or endotoxin) and peptidoglycans from bacteria, and β-1,3-glucans
from fungi (1). Vertebrate pattern recognition molecules also specifically recognize and bind to
endogenous and exogenous mannose-terminating glycoproteins and peptides (2). These
recognition proteins and their receptors belong to the lectin superfamily (i.e. sugar binding
proteins) and are coupled to effector functions, such as complement activation in mammals (2)
and prophenoloxidase system (proPO) activation in invertebrates (1). These functions activate
the cellular and humoral components of the immune system to provide biological defense for the
animal (1,2,3). Depleted levels of lectins have been shown to predispose mammals to severe and
recurrent infections (4,5).
In the case of humans and other vertebrates, the structurally conserved lipid A portion of
smooth (S) or rough (R) form lipopolysaccharide (LPS), from intact gram-negative bacteria or
that released by bacteria into serum, is bound with high stoichiometric affinity by a soluble 60kD carrier acute-phase glycoprotein, the LPS-binding protein (LBP) (6,7). The LPS-LBP
complex then binds to leukocytes through a 55-kD glycoprotein receptor, the monocytic
differentiation antigen CD14. CD14 is attached to the eukaryotic membrane via a
phosphatidylinositol glycan anchor and is mobile in the plane of the membrane. After specific
binding to LPS or LBP, CD14 is responsible for the signal transducing events leading to cell
activation (8). LPS in the presence of LBP is more effective than LPS alone in activating
leukocytes (6). Activated monocytes and macrophages respond to LPS at nanogram per
milliliter concentrations by inducing the secretion of lipid products of arachidonic acid, toxic
oxygen radicals, and cytokines, such as tumor necrosis factor-α (TNF-α). The cellular
expression of intercellular adhesion molecules (ICAM-1) and induction of enzymes involved in
the synthesis of small proinflamatory mediators are also enhanced (1). Polyclonal antibodies
against LBP (anti-LBP) immunoprecipitated R and S form LPS from LPS mixtures and normal
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mammalian plasma. Immunodepletion of LBP from normal plasma, with anti-LBP polyclonal
goat immunoglobulin G (IgG), resulted in inhibition of R and S form LPS-induced TNF-α
production by rabbit leukocytes (7). Furthermore, a blockade of anti-CD14 monoclonal
antibodies was shown to down-modulate the binding to CD14 of sheep erythrocytes coated with
LPS-LBP complexes and to block the LPS-stimulated synthesis of TNF-α (8).
In addition, human mononuclear phagocytes and murine macrophages possess a
membrane receptor, composed of 2 disulfide-linked polypeptide chains, that has ligand
specificity for the β-glucans commonly found in yeast and fungi. This receptor initiates the
phagocytosis of these organisms in the absence of opsonins (9).
The vertebrate mannose receptor, also referred to as the mannose-fucose receptor, is
present on the surface of mononuclear phagocytes (macrophages and denditric cells) and on nonimmune cells, such as hepatic endothelial cells, kidney glomeruli cells, and tracheal smooth
muscle cells (2,3,5). It is a type I transmembrane glycoprotein (165-kD). Its extracellular
domain consists of 8 different Ca2++-dependent (C-type) carbohydrate recognition domains
(CRDs), a fibronectin type II repeat, and a cysteine rich segment (10). The 8 CRDs are
responsible for recognition of and high affinity binding to different molecular patterns (11).
Stahl et al. (12) have shown that the rate at which β-glucuronidase (a lysosomal glycosidase) is
cleared from rat plasma sharply decreases when fucose- (Fuc), mannose- (Man), N-acetyl-Dglucosamine- (GlcNac), and xylose- (Xyl) coupled to bovine serum albumin (neoglycoproteins)
are simultaneously administered. The following order of decreasing affinity for the mannose
receptor has been established: L-Fuc = D-Man > GlcNac ≅ D-glucose > D-Xyl > > > D-galactose
= L-arabinose = D-Fuc. These molecules are both ligands and inhibitors of the mannose
receptor, and they are the terminal oligosaccharides of glycoproteins and peptides frequently
found on the surfaces of microorganisms.
Several glycoproteins, including horseradish peroxidase and mannan, have been shown to
serve as ligands and to effectively inhibit ligand binding by the mannose receptor (13).
Horseradish peroxidase has an 86% carbohydrate content, and it consists predominantly of
mannose and glucosamine and lesser and varying amounts of fucose, xylose, and arabinose (14).
The principal antigen of yeast is its cell wall mannan component. Mannan is composed almost
entirely (50-90%) of highly branched poly-D-mannose chains that have 1→2, 1→3, and 1→6
11

linkages between the sugar units (15). Macrophage uptake of β-glucuronidase is nearly
completely inhibited when excess yeast mannan is simultaneously administered (12).
The mannose binding protein (MBP) is a soluble acute phase protein. It consists of both
lectin and collagen domains, which are organized as bouquets containing 2 to 6 building blocks
with 3 terminal CRDs (2). It functions as an opsonin, modulates the host inflammatory response
to infections and enhances the uptake of MBP-pathogen complexes via the mannose receptor.
MBP displays ligand affinity and specificity similar to that of the mannose receptor (3,4),
including specific binding to some strains of LPS (11). The structure and composition of
bacterial endotoxins have a major influence on MBP and mannose receptor binding. For
instance, MBP was shown to bind specifically to the nonreducing terminal N-acetyl-Dglucosamine and D-mannoheptose residues present in the rough outer core polysaccharide of
Salmonella Ra chemotype LPS but not to smooth Re chemotype LPS (4). The binding of MBP
to these carbohydrate residues of LPS activates the complement cascade in an antibody and C1q
independent manner (4,16). The structures of smooth and Re chemotype endotoxin mask the
mannose (when present) and N-acetyl-D-glucosamine residues. They also alter the sugar density
or conformation of the LPS molecules in order to prevent lectin ligation (4).
The mannose receptor mediates macrophage phagocytosis of unopsonized and opsonized
bacteria (Escherichia coli, Pseudomonas aeruginosa, Mycobacterium tuberculosis), fungi
(Candida albicans, Pneomocystis carinii) and some enveloped viruses (human
immunodeficiency virus type 1, influenza A) in the vertebrate innate immune response (3,4). It
is also responsible for the endocytic clearance of endogenous soluble proteins that bear highmannose oligosaccharides (i.e. lysosomal enzymes and tissue plasminogen activator) (4).
Further downstream events that have also been coupled to the interactions between the mannose
receptor and its ligands include: the release of lysosomal enzymes, reactive oxygen
intermediates, arachidonic acid metabolites, and cytokines (IL-1, IL-6, IL-12, GM-CSF, TNF-α),
and the efficient delivery of captured antigens to major histocompatability complex (MHC)
Class II-containing compartments. These functions indicate the existence of signal transducing
ability and possible receptor roles in facilitating antigen uptake, processing, and presentation in
the adaptive immune response of vertebrates. The mannose receptor may represent a link
between innate and adaptive immunity (4).
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Invertebrate animals, such as the crayfish Procambarus clarkii, mount extremely
efficient cellular and humoral innate immune responses against invading pathogens and “nonself” molecules present in their freshwater environments (17). However, they lack an adaptive
immune system and, hence, production of antigen specific antibodies (18). Despite the structural
and chemical barrier formed by the hard exoskeleton in these animals, invading parasites and
pathogenic and non-pathogenic microorganisms can enter the body cavity through a wounded
cuticle, through the alimentary canal, or during the molt and establish an active infection
(1,17,18,19,20). Their cellular defense mechanisms reside in the activities of circulating
hemocytes (17). These cells participate in phagocytosis, encapsulation or nodule formation, and
synthesis and exocytosis of the clotting cascade, the prophenoloxidase-activating system, and
other antibacterial proteins and peptides (1). They also participate in nutrient transport and
waste removal throughout the body (21). Three distinct populations of hemocytes have been
isolated, separated, and morphologically described under electron and phase contrast microscopy
(22,23,24). Their relative behavior and function in vitro have been partially clarified (23,24).
All 3 hemocyte populations attach to the glass surface of coverslips within 20 minutes (24).
The hyaline cells are the most abundant hemocyte type (about 75-77%) (22). They have
a hyaline cytoplasm with flat pseudopodia extending from a pleomorphic surface, contain no
granules, and have a high nucleo-cytoplasmic ratio (17,22). Hyaline hemocytes are phagocytic
(17). Semigranular cells are ovoid or fusiform in shape, are present in low numbers (about 89%), have a low nucleo-cytoplasmic ratio, and contain a variable number of small, round, or
slightly oval granules that appear eosinophillic when stained with Wrights stain (22). According
to Soderhall et al. (17,24), semigranular hemocytes display limited phagocytic ability. However,
they are the principal cells involved in encapsulation reactions, and the only cells to specifically
degranulate in response to direct exposure to lipopolysaccharides and β-1,3-glucans (17).
Granular cells demonstrate mainly spherical shapes, have low nucleo-cytoplasmic ratio, are more
numerous than semigranular hemocytes (15-16%), and contain large granules (17,24). Granular
hemocytes are not phagocytic. Their granules, like those of the semigranular cells, are
repositories for the prophenoloxidase activating system (proPO system) (19). They undergo
exocytototic release only when triggered by an endogenous 76 kD factor and an endogenous β1,3-glucan binding protein previously exposed to β-1,3-glucans (17, 19).
13

Several invertebrate pattern recognition molecules have been found and partially
characterized, although the exact nature of their interactions with antigen is not yet known. For
instance, Yashida and coworkers (25) purified and described a unique, single chain 19kDa
hemolymph protein from the silkworm Bombyx mori. This defense protein binds with high
affinity to molecules of peptidoglycan and triggers the release and activation of the proPO
cascade (1, 25). In the horseshoe crab Tachypleus tridentatus, LPS and β-1,3-glucans bind to
factors C and G, respectively, and initiate the hemolymph clotting cascade. Both proteins are
intracellular serine protease zymogens. They undergo conformational changes and are
autocatalytically converted to their biologically active forms following antigen ligation (26).
Interestingly, factor C contains vertebrate complement domains, suggesting that invertebrates
also possess complement-like factors for defense (27).
Furthermore, a β-1,3-glucan binding protein (βGBP), a β-1,3-glucan-binding- protein
membrane receptor, and a LPS and β-1,3-glucan binding protein (LGBP) from the freshwater
crayfish Pacifastacus leniusculus have been purified and described (1,28). βGBP is a
monomeric plasma glycoprotein of 100kDa. It becomes activated after reacting to β-1,3glucans, but not to mannans, undergoes a conformational change, and binds to the specific β-1,3glucan-binding-protein hemocyte membrane-receptor (1). This is the only receptor that has so
far been purified from invertebrate hemocytes, and it consists of 2 non-covalently associated
polypeptide subunits of 230 kDa and 90 kDa (28). Its ligation to βGBP induces the exocytotic
release of an inactive proPO system and of LGBP (1).
The mature LGBP consists of 346 amino acid residues and has a molecular mass of 36
kD and 40 kD on 10% SDS-polyacrylamide gel electrophoresis under reducing and nonreducing
conditions, respectively. LGBP binds specifically to LPS and β-1,3-glucans (i.e. laminarin,
curdlan), but not to peptidoglycan, and activates the released proPO. A blockade of anti-LGBP
antibodies significantly inhibits the phenoloxidase activity of hemocyte lysate. LGBP shows
significant amino acid sequence homology with several previously reported invertebrate Gramnegative bacteria-binding proteins and β-1,3-glucanases (1).
All these endogenous invertebrate proteins recognize antigenic molecules, mediate the
attachment between hemocyte surfaces and “non-self” entities in the hemolymph, and activate
the host cellular and humoral immune responses (17). In particular, low concentrations of
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microbes or microbial molecules in the hemolymph are phagocytized by hyaline hemocytes and,
to a limited extent, by semigranular hemocytes (17, 18). When higher concentrations are
present, increasing numbers of semigranular cells aggregate on and around the foreign particles.
These aggregates form capsules consisting of densely packed hemocyte layers, which entrap and
seal off the intruders from the circulation (29). Concomitant degranulation of semigranular and
granular hemocytes also occurs (17,18,29).
Throughout the animal kingdom, this receptor-mediated exocytotic release of proteins
from cellular vesicles in response to various stimuli is a fundamental process (30). The
exocytosis of granular contents from hemocytes into the external milieu in response to
endotoxin, peptidoglycans, and β-1,3-glucans confers humoral immunity to invertebrates (17).
For instance, the clotting cascade, the proPO-activating system, and a broad spectrum of
antibacterial proteins and peptides are released into the plasma and are activated (1,17,24).
These invertebrate humoral immune components act in concert with the cellular immune
functions of phagocytosis and encapsulation (17). This interplay leads to a strong host defense
mechanism (17) and a short-lived increased resistance to certain pathogens following prior
exposure to them or their cell wall polysaccharides (31).
Once released from the hemocytes, the complete activation of the clotting cascade
induces coagulogen molecules (also sequestered in and released from hemocyte granules) to
polymerize like vertebrate fibrinogen and form the coagulin gel (26). The coagulin gel is an
insoluble clot that seals wounds and entraps parasites (17,26).
The proPO system is also activated after its exocytotic release. ProPO-activating
enzymes (endogenous serine proteases) proteolytically cleave prophenoloxidase and convert it to
the biologically active phenoloxidase (monophenyl L-dopa: oxygen oxidoreductase) (19, 24).
This redox enzyme is the terminal component of the proPO system. Phenoloxidase crosslinks
LPS to a still unidentified LPS receptor on the hemocyte surface, and it catalyzes the oxidation
of phenols to quinones (17). Quinones then undergo several nonenzymatic polymerization steps
and form melanin (1,17,32). This final product melanizes (blackens) pathogens, including those
already entrapped by the coagulin gel and the encapsulation reaction, hardens the cuticle, and
heals wounds (1,17). Melanin and its intermediates, such as 3,4-dihydroxyphenylalanine and
hydrogen peroxide, are also highly reactive compounds that can prevent growth of bacteria and
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some fungi by inhibiting their extracellular proteinases and chitinases (32). Furthermore, the 76
kD factor (an opsonin) and the β-1,3-glucan binding protein, both components of the proPO
system, have been shown to participate in intercellular communication by functioning as cell
adhesion factors. They trigger adjacent hemocytes to adhere to and encapsulate the foreign
particles and to degranulate, thereby amplifying the invertebrate cellular and humoral immune
responses (17).
Still unidentified components of the proPO system also appear to increase the phagocytic
rate of hyaline hemocytes and to be involved in the clotting cascade. The proPO cascade is,
therefore, the centerpiece of internal defense in crustaceans (33). It resembles the vertebrate
complement cascade because it produces fungistatic, opsonic, lytic, and degranulating factors
(34). However, unlike vertebrate complement, the proPO cascade is localized within the
secretory vesicles of semigranular and, above all, granular cells (19,34).
Other hemocyte components with potent antimicrobial properties are also exocytotically
released from invertebrate circulating hemocytes along with the proPO system (17, 32). These
include the tachyplesin cationic peptides, which even at low concentrations nonspecifically
permeabilize bacterial and fungal membranes and cause irreversible loss of viability (26).
Because the production of antimicrobial peptides occurs within a few hours after the entry of a
bacterium or fungus, some sort of signal transduction must occur following receptor ligation of
the antigen (32). Interestingly, the mature tachyplesin peptides are stored within granules, just as
mammalian cationic antibacterial peptides (i.e. defensins) are sequestered within the azurophilic
granules of neutrophils (26, 35).
Pattern recognition molecules of innate immunity recognize, localize, and help to
neutralize microbial invaders (2). In mammals, the response to an infectious challenge consists
of a reciprocal interplay between innate and adaptive immunity, and this interplay leads to a
systemic state of increased resistance to invading pathogens (3). Although invertebrates lack
adaptive immunity (17), a thorough understanding of innate immune mechanisms is necessary
because a disruption in innate immunity can adversely affect antigen specific adaptive responses
in higher animals (3). So far, only the hemocyte membrane receptor with specificity for βGBP
has been identified in invertebrates (28). The overall aim of the work presented here was to
establish the possible presence of LPS and mannose receptors on the surface of distinct
16

subpopulations of circulating hemocytes from the red swamp crayfish Procabarus clarkii. This
is apparently the first report to provide evidence for the presence and localization of these
receptors in the granular hemocytes of this invertebrate species.
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CHAPTER 2
MATERIALS AND METHODS
Animals
Red swamp crayfish, Procambarus clarkii, were purchased from Waubun
Laboratories, Inc. (Shriever, LA) through Carolina Biological Supply, Co. (Burlington, N.C.),
maintained in aerated freshwater aquaria at 25°C, and fed every 3 to 4 days with guinea pig
pellets (The Hartz Mountain Corporation, Secaucus, NJ). Only apparently healthy intermoult
adult crayfish were used in these experiments. Prior to bleeding, all animals were anesthetized
in ice water for approximately 5 minutes.
Preparation of Reagents and Serial Dilutions
Reconstitutions and serial dilutions of ligands and inhibitors were made in sterile 0.15M
NaCl dissolved in double distilled water, using sterile polypropylene pipette tips and sterile,
nonpyrogenic, 5ml disposable 12x75mm polysterene round-bottom tubes (Fisher Scientific,
Pittsburgh, PA). The following mixtures were made, and each solution was vigorously vortexed
before transfer and experimental use to ensure homogeneity.
Fluorescein Isothiocyanate-Lipopolysaccharide
One mg of lyophilized and chromatographically purified powder of fluorescein
isothiocyanate-lipopolysaccharide (FITC-LPS) was obtained from Sigma Chemical Company,
St. Louis, MO. It was prepared from the smooth lipopolysaccharide of E. coli, serotype
0111:B4, and it contained 2-10µg FITC per mg LPS. The FITC-LPS powder was reconstituted
and serially diluted to concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 FITC-LPS.
Streptavidin-FITC
One ml of Streptavidin-FITC (SFITC) was purchased from Southern Biotechnology
Associate, Inc., Birmingham, AL. It was serially diluted in sterile 0.15M NaCl to concentrations
of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 SFITC.
18

Avidin-Rhodamine Isothiocyanate
One mg of lyophilized powder of avidin-rhodamine isothiocyanate (ARITC) was
obtained from Sigma Chemical Company, St. Louis, MO. It contained 1-2 moles of rhodamine
isothiocyanate per mole of avidin. The ARITC powder was reconstituted and serially diluted to
concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 ARITC.
Bovine Albumin, Fraction V
One point six mg fraction V of bovine albumin (BSA) was obtained from Sigma
Chemical Company, St. Louis, MO. It was reconstituted and diluted to a concentration of 1µg
ml-1 BSA conjugate.
Bovine Albumin-α-D-Mannopyranosylphenyl Isothiocyanate-Biotin Labeled
One mg of lyophilized powder of bovine albumin-α-D-mannopyranosylphenyl
isothiocyanate-biotin labeled (MBSA-biotin) was obtained from Sigma Chemical Company, St.
Louis, MO. It contained 15-20 moles α-D-mannopyranose and 1.5-3.0 moles flurescein per
mole albumin. The powder was reconstituted and diluted to a concentration of 1µg ml-1 MBSAbiotin.
Lipopolysaccharide
One mg of detoxified, lyophilized and chromatographically purified powder from the
smooth lipolysaccharide (LPS) of E. coli, serotype 0111:B4, was obtained from Sigma Chemical
Company, St. Louis, MO. The LPS powder was reconstituted and serially diluted to
concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 LPS.
Mannan
Ten mg of mannan powder from Saccharomyces cerevisiae was obtained from Sigma
Chemical Company, St. Louis, MO. The mannan powder was reconstituted and serially diluted
to concentrations of 125, 100, 50, 25, 10, and 1 µg ml-1 mannan. Higher serial dilutions of 100,
10, and 1 ng ml-1, and 100 pg ml-1 mannan were also made.
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Horseradish Peroxidase Type XI
Lyophilized powder of peroxidase (apoperoxidase) from horseradish (HRP) was obtained
from Sigma Chemical Company, St. Louis, MO. It was reconstituted and serially diluted to
concentrations of 100, 50, 25, 10, and 1 µg ml-1 HRP.
Bleeding and Preparation of Hemocytes
Hemolymph was withdrawn from individual crayfish (2 to 3 animals for receptor binding
and inhibition assays; 5 to 7 animals for the Percoll discontinuous gradients) by puncturing the
abdominal hemocoel with a 22 gauge sterile needle. The hemolymph was collected into a 3 cc
sterile syringe (Fisher Scientific, Pittsburgh, PA), containing 0.5 ml of citrate/EDTA crayfish
anticoagulant buffer of pH 4.6 (23, see Appendix). The crayfish anticoagulant buffer was
precooled at 4°C. Citric acid in the anticoagulant buffer delayed cell break down, while EDTA
inhibited the activation of the clotting and prophenoloxidase cascades (23). The hemolymph
expressed from individual syringes was pooled into a sterile 15 ml disposable centrifuge tube
(Fisher Scientific, Pittsburgh, PA), and it was mixed with a sterile Pasteur pipette. A small
aliquot (~ 150 µl) was removed, and a 0.100-millimeter deep Neubauer Brightline
hemocytometer (Hausser Scientific) was used to determine total hemocyte counts in the
hemolymph by examination under phase contrast optics (400x objective lens) of an Olympus
BH-2-RFCA microscope (Olympus Optical Co., LTD, Japan). If the hemolymph contained
bacterial contamination, it was discarded. If it did not, it was centrifuged in a swinging bucket
centrifuge (IEC CENTRA-8R) for 10 minutes at 1,200 x g at 10°C. The supernatant, containing
hemolymph and anticoagulant, was discarded. The hemocyte pellet was resuspended by mixing
with a sterile Pasteur pipette x 20 in sterile TNM-FH insect medium (see Appendix), which was
obtained from Sigma Chemical Company, St. Louis, MO. Before performing further
experimental procedures, a small aliquot (~ 150 µl) was again removed, and total hemocyte
counts were determined using the Neubauer Brightline hemocytometer. The hemocyte
suspension, if necessary, was further diluted in TNM-FH insect medium to achieve a
concentration of between 4.0 to 7.0 x 106 cells ml-1.
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For each assay, duplicate, 22 x 22 mm, clean and pyrogen-free glass coverslips (baked
for at least 4 hours at 200°C to inactivate endotoxin) were placed on the bottom of clean and
95% ethanol treated polystyrene multiwell (6-well, flat bottom) tissue culture plates (Fisher
Scientific, Pittsburgh, PA). Two drops of homogenous hemocyte suspension were dispensed
with a sterile Pasteur pipette onto the middle of each coverslip surface. The cells were allowed
to adhere to the glass coverslips by incubation at 20°C for 30 minutes. The cells were washed 10
times in 3 changes of sterile and nonpyrogenic crayfish saline, which is a balanced salt solution
that resembles the ionic composition of Astacus astacus hemolymph (24, see Appendix). The
cells were fixed in 100% methanol for 2 minutes at 25°C, and they were washed again 10 times
in 3 changes of sterile crayfish saline. All hemocytes for inhibition and standard binding assays
were prepared and fixed in this manner prior to further experimental procedures.
Standard Ligand Binding Assays for Potential LPS and Mannose Receptors
Fixed hemocytes were incubated for 30 minutes at room temperature with FITC-LPS as
ligand for potential LPS receptors. Fixed hemocytes were also incubated for 30 minutes with
MBSA-biotin (1 µg ml-1) as ligand for potential mannose receptors. The MBSA-labeled
hemocytes were further incubated for 30 minutes with the SFITC and/or ARITC exogenous
fluorescent probes. For the initial standardization assays, the concentrations of FITC-LPS,
SFITC and ARITC varied over a wide range in order to ascertain the best concentration required
for binding to hemocytes. The best concentrations of those tested were used thereafter in every
experiment. The control for FITC-LPS consisted of 0.15M NaCl; for streptavidin-FITC and/or
ARITC, it consisted of incubation with 1 µg ml-1 of BSA conjugate, followed by incubation with
SFITC and/or ARITC. Each assay condition was tested in duplicates.
All ligands and reagents were dispensed with an individual sterile Pasteur pipette directly
onto each coverslip surface that contained adhered and methanol fixed hemocytes. They
completely covered the cells and the coverslip surface. After the reactions were allowed to
proceed for 30 minutes at room temperature and in the dark, the cells were washed 10 times in 3
changes of sterile and nonpyrogenic crayfish saline to remove unbound ligand or label.
At the end of each experiment, the coverslips were mounted face down on glass slides
using immunofluorescence mounting medium (36, see Appendix). Ten random fields were
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scanned (or at least 1000 cells at random), and the hemocytes were visualized and counted using
phase contrast and fluorescence microscopy (490 nm excitation and 520 nm emission
wavelengths for FITC, and 541 nm excitation and 572 nm emission wavelengths for ARITC)
with 400x magnification. The percentage of fluorescent cells was calculated from the total
hemocytes counted. The positive percentages are shown for each assay condition along with the
mean of the three parallel experiments + standard error of the mean (S.E.M.). With the
exception of the standardization binding assays, all experiments have been performed 3 times.
Inhibition of Ligand Binding to Hemocytes
The inhibition assays were performed under similar conditions as the standard assays.
However, the concentrations of the LPS, mannan, and horseradish peroxidase inhibitors varied
over a large range, while, in the next steps of the protocol, the concentrations of ligand and label
(when applicable) remained constant. The inhibitor was dispensed with a sterile Pasteur pipette
directly onto each coverslip surface, and it completely covered the cells and the coverslip
surface. After incubation for 30 minutes in the dark at room temperature (25°C) and prior to
ligand presentation in the standard binding assays, the cells were washed as in the standard
protocol.
The percentage of fluorescent cells was calculated from the total hemocytes counted.
The positive percentages are shown for each assay condition along with the mean of the 3
parallel experiments + standard error of the mean (S.E.M.). Analysis of statistical differences for
the inhibition assays, in a series of 3 experiments, were made by comparing the mean percent of
fluorescent hemocytes obtained for each inhibitor concentration used with that of the control that
was not presented with the inhibitory ligand. The means are significantly different at p < 0.05
(paired t test).
Normality check and 2-way analysis of variance (2-way ANOVA), followed by the least
significant difference (LSD) multiple comparisons test, were performed and interpreted for the
inhibition studies that used LPS to prevent the binding of FITC-LPS to hemocytes. The LSD
multiple comparisons test revealed that the groups are significantly different if the difference
between group means is greater than the LSD value. An F-ratio >> 1and a p value < 0.05 also
indicated significant difference among group means.
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Preparation of Gradients and Enrichment of Hemocyte Subpopulations
The Percoll gradient was initially calibrated using density marker beads (Sigma Chemical
Company, St. Louis, MO). The different hemocyte subpopulations of P. clarkii were isolated
and enriched using a modification of a standard technique, which was previously reported for
marine and freshwater crustaceans (23,24). A 40%, 50%, and 60% discontinuous Percoll (Sigma
Chemical Company, St. Louis, MO) density gradient was prepared in sterile and nonpyrogenic
0.15M NaCl solution, which was precooled at 4°C. The Percoll solution was layered (3 ml per
concentration) in 2 sterile 15 ml Fisher disposable centrifuge tubes without disturbing the
gradients. One ml of hemocyte suspension was aseptically layered on top of each preformed
Percoll discontinuous gradient, and the tubes were centrifuged in the swinging bucket centrifuge
at 3,500 x g for 20 minutes at 10°C. The resulting hemocyte bands (band 1, 2, and 3) were
individually and aseptically collected. The cells were further diluted and washed in sterile
0.15M NaCl, to prevent the formation of another gradient, and they were centrifuged at 1,200 x g
for 10 minutes at 10°C. The cells in band 1 were usually resuspended and diluted in TNM-FH
insect medium to a concentration of around 5.0 to 7.0 x 106 cells ml-1. Bands 2 and 3, due to
usually low recovery rates, were diluted in 0.5 ml TNM-FH insect medium to a concentration of
between 20 to 50 x 104 cells ml-1. The hemocyte types present in each gradient fraction after
resuspension were identified by examination under phase contrast optics. The hemocytes were
counted, and they were prepared and used for the standard binding assays.
Confocal Laser Scanning Fluorescence Microscopy
A mixed population of P. clarkii hemocytes was double immunolabeled, as described in
the standard binding assays, with MBSA-biotin, ARITC, and FITC-LPS. A Leica confocal laser
scanning microscope (CLSM) was used to obtain images of these cells. The CLSM was
equipped with 2 different lasers: an Argon ion laser emitting at 488 nm to excite FITC, and a
HeNe laser emitting at 543 nm to excite ARITC. The same double immunolabeled hemocytes
were studied in 2 ways: 1) by sequential excitation with each laser on, and 2) by superposition of
the same optical section images that were obtained from the sequential excitation of the cells
with each laser on. The superposition of the 2 images resulted in a combined 2-color FITC23

ARITC image of the hemocyte surface. The FITC signal (520 nm emission wavelength) was
displayed on the monitor in the pseudo-color green. The ARITC signal (572 nm emission
wavelength) was displayed in pseudo-red. A 200x magnification was enlarged 8 times on the
monitor, resulting in a total 1,600x magnification of the recorded image.
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CHAPTER 3
RESULTS
The Best Concentration of FITC-LPS Required for Binding to Procambarus clarkii Hemocytes
To ascertain the best concentration of FITC-LPS required for binding to potential LPS
receptors on the surface of P. clarkii hemocytes, a series of 2 experiments, in which the
concentration of ligand varied over a wide range, was performed. The results indicate 5 µg ml-1
FITC-LPS to be the best concentration of those tested (Table 1). This concentration yielded an
average 7.0% of fluorescent cells. When the concentration of the exogenous fluorescent probe
conjugated to LPS was below 5 µg ml-1, it was difficult to determine if the observed fluorescence
signal was obtained from the autofluorescence of hemocytes or from the FITC-LPS bound to the
cell surface. In this case, the percent of fluorescent cells dropped to an average of 3%.
Increasing the concentration of FITC-LPS above 5 µg ml-1 yielded no detectable increase in the
percent of fluorescent cells.
The Best Concentration of SFITC and ARITC Required for Binding to MBSA-Biotin Labeled
Procambarus clarkii Hemocytes
A series of 2 experiments per fluorescent probe was performed to ascertain the best
concentrations of SFITC and ARITC required for binding to P. clarkii hemocytes that were
initially exposed to MBSA-biotin (1µgml-1). The concentrations of these ligands varied over a
wide range. The results in Table 2 indicate 1 µg ml-1 SFITC to be the best concentration of those
tested, yielding an average 9.8% of fluorescent cells. Increasing the concentration of the SFITC
exogenous fluorescent probe above 1 µg ml-1 yielded no significant increase in the percent of
fluorescent cells that displayed distinct green granular fluorescence. A SFITC concentration
below 1 µg ml-1 was not tested.
The best concentration from those tested of ARITC, which was required for binding to
MBSA-biotin labeled hemocytes, was 5 µg ml-1 (Table 3). This concentration yielded an
average 5.9% of fluorescent cells. When the concentration of the ARITC was below this level,
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Table 1. The Best Concentration of FITC-LPS Required for Binding to Procambarus clarkii Hemocytes

%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Avg.+S.E.M.

Control (0.15M NaCl)

0

0

0

2282

FITC-LPS (1 µg ml-1)

3.3

2.9

3.1+0.20

2505

FITC-LPS (2.5 µg ml-1)

3.5

2.5

3.0+0.50

3157

FITC-LPS (5 µg ml-1)

7.1

6.9

7.0+0.10

2780

FITC-LPS (10 µg ml-1)

6.8

7.0

6.9+0.10

2718

FITC-LPS (15 µg ml-1)

6.1

6.8

6.5+0.35

3021

FITC-LPS (20 µg ml-1)

6.4

7.4

6.9+0.50

2864

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Table 2. The Best Concentration of SFITC Required for Binding to MBSA-Biotin Labeled Procambarus clarkii Hemocytes
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Avg.+S.E.M.

Control (1 µg ml-1 BSA)

0

0

0

2499

SFITC (1 µg ml-1)

10.3

9.3

9.8 + 0.50

3033

SFITC (2.5 µg ml-1)

9.8

8.7

9.3 + 0.55

2455

SFITC (5 µg ml-1)

9.6

9.6

9.6

2422

SFITC (10 µg ml-1)

8.5

9.6

9.1 + 0.55

2210

SFITC (15 µg ml-1)

10.9

10.6

10.8 + 0.15

2131

SFITC (20 µg ml-1)

9.9

9.9

9.9

2898

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Table 3. The Best Concentration of ARITC Required for Binding to MBSA-Biotin Labeled Procambarus clarkii Hemocytes
%Fluorescent Cellsa

Treatment

nb

Exp.1

Exp. 2

Avg.+S.E.M.

Control (1 µg ml-1 BSA)

0

0

0

3348

ARITC (1 µg ml-1)

3.1

3.9

3.5 + 0.40

2875

ARITC (2.5 µg ml-1)

2.3

3.7

3.0 + 0.7

3639

ARITC (5 µg ml-1)

5.7

6.0

5.9 + 0.15

3326

ARITC (10 µg ml-1)

4.9

6.5

5.7 + 0.80

3683

ARITC (15 µg ml-1)

4.6

5.8

5.2 + 0.60

3558

ARITC (20 µg ml-1)

5.1

6.5

5.8 + 0.70

3407

a

Cells displaying red and distinct granular fluorescence at 572 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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the fluorescent cells became more difficult to count. The percent of fluorescent cells
dropped to an average of 3% and 3.5% at 1 µg ml-1 and 2.5 µg ml-1, respectively. An
ARITC concentration below 1 µg ml-1 was not tested. Increasing the concentration of
ARITC above 5 µg ml-1 yielded no significant increase in the percent of fluorescent cells
that displayed distinct red granular fluorescence. The best ligand concentrations were
used thereafter in every experiment.
Effect of LPS on the Observed Number of Fluorescent Procambarus clarkii Hemocytes
Inhibition assays in a series of 3 experiments were used to analyze the inhibitory
potency of LPS from the smooth lipolysaccharide of E. coli, serotype 0111:B4, on the
observed number of fluorescent P. clarkii hemocytes. The cells were subsequently
incubated with FITC-LPS and with MBSA-biotin conjugated to ARITC. The LPS
portion of FITC-LPS was also prepared from the smooth lipopolysaccharide of E. coli,
serotype 0111:B4.
Hemocytes adhered to glass coverslips and fixed in methanol were incubated with
various concentrations of LPS, and binding was allowed to occur for 30 minutes prior
to FITC-LPS presentation. As a control, 0.15M NaCl was added to hemocytes, and no
fluorescent cells above the level of autofluorescence were detected. As shown in Table
4, LPS concentrations of 1.25 µg ml-1, 2.5 µg ml-1 and 5 µg ml-1 caused a 38% decrease
in the observed number of fluorescent hemocytes. A nearly 73% reduction in the
observed number of fluorescent hemocytes was achieved by concentrations between 10
and 40 µg ml-1 LPS.
In contrast, similar LPS concentrations were ineffective in decreasing the number
of hemocytes that bound MBSA-biotin and, subsequently, ARITC (Table 5). The
percentage of fluorescent cells only fluctuated between 7.8-9.3%. As a control,
hemocytes were incubated with 0.15M NaCl, followed by BSA and ARITC, and no
fluorescent cells above the level of autofluorescence were detected. Figure 1 graphically
summarizes these results. It indirectly indicates, based on the observed percentage of
fluorescent cells, that whereas LPS effectively inhibited the binding of FITC-LPS to P.
clarkii hemocytes, it had no effect on the binding of the MBSA-biotin to these cells.
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Table 4. Effect of Different LPS Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes Presented
with FITC-LPS
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (0.15M NaCl)

0

0

0

0

2521

Control (5 µg ml-1 FITC-LPS)

6.8

5.5

6.2

6.2 + 0.38

1697

LPS (1.25 µg ml-1)

4.0

3.5

4.1

3.9 + 0.19

2581

LPS (2.5 µg ml-1)

3.9

3.5

3.9

3.8 + 0.13

2465

LPS (5 µg ml-1)

3.9

3.4

4.5

3.9 + 0.32

2258

LPS (10 µg ml-1)

1.5

1.2

2.0

1.6 + 0.23

2693

LPS (20 µg ml-1)

2.2

1.6

2.0

1.9 + 0.18

3409

LPS (40 µg ml-1)

1.6

1.7

2.0

1.8 + 0.12

3338

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Table 5. Effect of Different LPS Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes Presented
with MBSA-Biotin and ARITC
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (1 µg ml-1 BSA)

0

0

0

0

2984

Control (1 µg ml-1 MBSA-biotin)

7.7

10.1

8.3

8.7 + 0.72

2587

LPS (1.25 µg ml-1)

8.1

10.0

8.4

8.8 + 0.59

2841

LPS (2.5 µg ml-1)

7.5

9.8

8.1

8.5 + 0.69

2965

LPS (5 µg ml-1)

8.8

8.8

7.7

8.4 + 0.37

2672

LPS (10 µg ml-1)

8.6

10.3

8.5

9.1 + 0.58

2776

LPS (20 µg ml-1)

6.5

8.2

8.8

7.8 + 0.69

2260

LPS (40 µg ml-1)

9.2

9.6

9.2

9.3 + 0.13

2994

a

Cells displaying red and distinct granular fluorescence at 572 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Figure 1. Effect of LPS on the Observed Number of Fluorescent Procambarus clarkii
Hemocytes.
LPS produced a concentration dependent decrease in the observed number of fluorescent
hemocytes when incubated with the cells for 30 minutes prior to FITC-LPS ()
presentation. Incubation with LPS for 30 minutes was ineffective in decreasing the
percentage of fluorescent cells, and, therefore, in decreasing the number of hemocytes
that subsequently bound MBSA-biotin and ARITC (z). Error bars are missing, because
the length of the error bar is less than the width of the point. * Asterisks and + crosses
indicate that the mean percentage of fluorescent hemocytes obtained for each
concentration of inhibitor used is significantly different, at p < 0.05, from the mean
percentage of fluorescent hemocytes of the control, which was not presented with the
inhibitory LPS ligand (paired t test). * Asterisks denote groups that are not significantly
different from one another, but that are significantly different from groups marked with +
crosses (2-way ANOVA followed by LSD multiple comparisons test). Similarly, +
crosses denote groups that are not significantly different from one another, but that are
significantly different from the groups marked with * asterisks. An LSD value smaller
than the difference between group means, an F-ratio >> 1and a p value < 0.05 indicated
significant difference among group means.
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Effect of Mannan on the Observed Number of Fluorescent Procambarus clarkii
Hemocytes
Inhibition assays in a series of 3 experiments were used to analyze the inhibitory
potency of mannan from S. cerevisiae on the observed number of fluorescent P. clarkii
hemocytes. These cells were presented with FITC-LPS and with the MBSA-biotin
subsequently conjugated to SFITC.
Various concentrations of mannan were layered on top of hemocytes adhered to
glass coverslips and fixed in methanol, and binding was allowed to occur for 30 minutes
prior to FITC-LPS presentation. The results in Table 6 indicate that even a high
concentration of 150 µg ml-1 mannan was ineffective in decreasing the observed number
of fluorescent hemocytes. The percentage of fluorescent cells was nearly identical to that
of the positive control (i.e. 7.9%). As a control, 0.15M NaCl was added to hemocytes,
and no fluorescent cells above the level of autofluorescence were detected.
Similarly, when the same mannan concentrations were layered on top of
hemocytes and binding was allowed to occur for 30 minutes prior to MBSA-biotin
followed by SFITC presentation, the percentage of fluorescent hemocytes remained
constant. It fluctuated between only 8.4% and 10% (Table 7). As a control, hemocytes
were incubated with 0.15M NaCl, BSA conjugate and SFITC. No fluorescent cells
above the level of autofluorescence were detected in the control. Mannan concentrations
in the nanogram ml-1 and picogram ml-1 range were also used as inhibitory ligands for
MBSA-biotin (data not shown). However, they were ineffective in decreasing the
observed percentage of fluorescent cells. The results in Tables 6 and 7 are graphically
summarized in Figure 2. These results indirectly indicate, based on the observed
percentage of fluorescent cells, that mannan had no inhibitory effect on the binding of the
FITC-LPS or the MBSA-biotin ligands to P. clarkii hemocytes.
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Table 6. Effect of Different Mannan Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes
Presented with FITC-LPS
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (0.15M NaCl)

0

0

0

0

2582

Control (5 µg ml-1 FITC-LPS)

8.2

7.1

8.3

7.9 + 0.38

2107

Mannan (1 µg ml-1)

8.5

6.2

7.8

7.5 + 0.68

2141

Mannan (10 µg ml-1)

7.4

7.9

8.4

7.9 + 0.29

2467

Mannan (25 µg ml-1)

7.2

7.4

6.7

7.1 + 0.21

Mannan (50 µg ml-1)

6.8

7.3

8.2

7.4 + 0.41

2447

Mannan (100 µg ml-1)

6.6

8.4

8.0

7.7 + 0.55

2397

Mannan (150 µg ml-1)

7.0

8.5

7.5

7.7 + 0.44

2731

a

2903

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Table 7. Effect of Different Mannan Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes
Presented with MBSA-Biotin and SFITC
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (1 µg ml-1 BSA)

0

0

0

0

1587

Control (1 µg ml-1 MBSA-biotin)

11.5

8.6

9.2

9.8 + 0.88

1422

Mannan (1 µg ml-1)

9.6

7.9

8.0

8.5 + 0.55

2047

Mannan (10 µg ml-1)

8.8

7.8

8.7

8.4 + 0.32

2224

Mannan (25 µg ml-1)

10.8

6.7

9.4

9.0 + 1.20

1470

Mannan (50 µg ml-1)

11.9

8.0

10.2

10.0 + 1.13

1198

Mannan (100 µg ml-1)

10.6

8.0

8.0

8.9 + 0.87

1090

Mannan (125 µg ml-1)

9.8

7.7

9.6

9.0 + 0.67

1442

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Figure 2. Effect of Mannan on the Observed Number of Fluorescent Procambarus
clarkii Hemocytes.
Incubation of hemocytes with mannan for 30 minutes prior to FITC-LPS presentation
(), and prior to MBSA-biotin followed by SFITC presentation (z) produced no
significant decrease, at p > 0.05, in the mean percent of fluorescent hemocytes when
compared with the mean percent of fluorescent hemocytes of the controls that were not
presented with mannan (paired t test). Error bars are missing, because the length of the
error bar is less than the width of the point.
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Effect of Horseradish Peroxidase on the Observed Number of Fluorescent Procambarus
clarkii Hemocytes
The inhibitory potency of various concentrations of horseradish peroxidase on the
observed number of fluorescent P. clarkii hemocytes incubated with FITC-LPS was
tested in a series of 3 experiments (Table 8). This glycoprotein appears to be an
ineffective antagonist of the FITC-LPS ligand because the percentage of fluorescent
hemocytes detected for each inhibitory assay concentration was similar to that of the
positive control (i.e. 6.5% fluorescent cells). As a control, 0.15M NaCl was added to
hemocytes. No fluorescent cells above the level of autofluorescence were detected in the
control.
In contrast, horseradish peroxidase at concentrations between 10 and 100 µg ml-1
decreased by 60% the number of fluorescent hemocytes exposed to MBSA-biotin and
SFITC (Table 9). A concentration of 1 µg ml-1 horseradish peroxidase did not result in a
reduction in the observed number of fluorescent hemocytes. As a control, hemocytes
were incubated with 0.15M NaCl, BSA conjugate and SFITC. No fluorescent cells
above the level of autofluorescence were detected in the control. These results are
graphically summarized in Figure 3.
A comparison of Figures 1, 2, and 3, as well as Tables 4 – 9, indicates that
whereas LPS effectively reduced the number of fluorescent hemocytes by 38% at low
concentrations and by nearly 73% at higher concentrations, it had no effect on the
binding of MBSA-biotin to hemocytes. LPS was, therefore, an effective inhibitor of
FITC-LPS binding to these cells. In contrast, horseradish peroxidase was a potent
antagonist for the binding of MBSA-biotin to hemocytes, decreasing by nearly 60% the
number of fluorescent cells. Horseradish peroxidase failed to inhibit the binding of
FITC-LPS to hemocytes because it had no effect on the observed percentage of
fluorescent cells. Mannan had no inhibitory effect on either ligand.
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Table 8. Effect of Different Horseradish Peroxidase Concentrations on the Observed Number of Fluorescent Procambarus clarkii
Hemocytes Presented with FITC-LPS
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (0.15M NaCl)

0

0

0

0

2782

Control (5 µg ml-1 FITC-LPS)

6.7

6.8

5.9

6.5 + 0.28

3018

HRP (1 µg ml-1)

6.3

5.8

6.8

6.3 + 0.29

3029

HRP (10 µg ml-1)

7.4

7.0

7.2

7.2 + 0.12

2680

HRP (25 µg ml-1)

7.9

6.6

7.4

7.3 + 0.38

2559

HRP (50 µg ml-1)

7.8

7.2

8.1

7.7 + 0.26

2861

HRP (100 µg ml-1)

6.3

7.6

6.3

6.7 + 0.43

2986

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Table 9. Effect of Different Horseradish Peroxidase Concentrations on the Observed Number of Fluorescent Procambarus clarkii
Hemocytes Presented with MBSA-Biotin and SFITC
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (1 µg ml-1 BSA)

0

0

0

0

2522

Control (1 µg ml-1 MBSA-biotin)

6.2

8.4

8.6

7.7 + 0.77

2569

HRP (1 µg ml-1)

5.5

7.3

7.6

6.8 + 0.66

2326

HRP (10 µg ml-1)

2.2

3.4

4.3

3.3 + 0.61

2595

HRP (25 µg ml-1)

2.8

2.6

2.7

2.7 + 0.06

3105

HRP (50 µg ml-1)

3.2

3.7

3.0

3.3 + 0.21

2426

HRP (100 µg ml-1)

2.1

2.3

3.4

2.6 + 0.40

2604

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in
Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Horseradish Peroxidase Concentration (µg ml )
Figure 3. Effect of Horseradish Peroxidase on the Observed Number of Fluorescent
Procambarus clarkii Hemocytes.
Incubation with horseradish peroxidase for 30 minutes, prior to FITC-LPS presentation
(), was ineffective in decreasing the percent of fluorescent hemocytes. In contrast,
horseradish peroxidase produced a concentration dependent decrease in the percent of
fluorescent hemocytes when incubated with the cells for 30 minutes prior to MBSAbiotin followed by SFITC presentation (z). Error bars are missing, because the length of
the error bar is less than the width of the point. *Asterisks indicate that the mean
percentage of fluorescent hemocytes obtained for each concentration of inhibitor used is
significantly different, at p < 0.05, from the mean percentage of fluorescent hemocytes of
the control that was not presented with the inhibitory ligand (paired t test).
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Enrichment of Procambarus clarkii Hemocyte Subpopulations Followed by FITC-LPS,
MBSA-Biotin and SFITC Presentation
Hemocyte subpopulations were isolated and enriched using a modification of a
standard technique previously reported for marine and freshwater crustaceans, which
employs a 40%, 50%, and 60% discontinuous Percoll gradient (14,15), in order to
determine which hemocyte subpopulation is responsible for binding to LPS and to
MBSA-biotin. The morphologically enriched but not pure cell subpopulations included
the hyaline, semigranular, and granular hemocytes collected from band 1, band 2, and
band 3, respectively. The enriched hemocytes were allowed to adhere to glass coverslips,
and they were fixed in methanol prior to ligand presentation.
In a series of 3 experiments, the enriched hemocyte subpopulations and a mixed
hemocyte population were incubated with FITC-LPS and with 0.15M NaCl as the control
(Table 10). No fluorescent cells above the level of autofluorescence were detected in the
control. The average percentage of fluorescent cells in the mixed hemocyte population
was 6.8%. The hyaline cells constituted the predominant hemocyte type of band 1. The
0.4% of fluorescent cells obtained from this band consisted entirely of hemocytes with
cytoplasmic granules. These hemocytes were somehow prevented from reaching the
50% or 60% discontinuous Percoll gradient interface or were accidentally introduced as
contaminants during the collection procedure. Band 2 consisted predominantly of
semigranular hemocytes. These cells displayed the typical fusiform morphology and
contained a variable number of small granules. The 4% of fluorescent cells detected in
this band following FITC-LPS presentation consisted, once again, of apparently granular
cells. These hemocytes were shielded by other cells from reaching the 60%
discontinuous Percoll gradient interface, or were introduced as contaminants during the
collection procedure. Lastly, band 3 contained mostly granular hemocytes, some
semigranular cells, and some very small and dense cellular entities that were not
observed prior to performing the discontinuous Percoll gradient enrichment procedure.
These cellular entities could, indeed, be the nuclei of lysed hemocytes. A comparison of
the percentage of fluorescent cells obtained from this band with that of the mixed
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Table 10. Binding of FITC-LPS to Enriched Hemocytes of Procambarus clarkii
Treatment

Cell
Band

%Fluorescent Cellsa

Predominant
Hemocyte
Type
Exp.1

nb

Exp.2

Exp.3

Avg.+S.E.M.

0

0

0

0

1953

FITC-LPS (5 µg ml )

7.5

6.5

6.5

6.8 + 0.33

2396

Control (0.15M NaCl)

0

0

0

0

2192

FITC-LPS (5 µg ml )

0.3

0.4

0.4

0.4 + 0.03

2479

Control

0

0

0

0

1349

1.8

2.7

7.6

4.0 + 1.80

1251

0

0

0

0

1129

20.2

25.7

26.4

24.1 + 1.96

1111

Control (0.15M NaCl)
-1

-1

FITC-LPS (5 µg ml-1)

⇒

⇒

⇒

Mixed

1

2

1

⇒

3

3

H ,SG ,G

H

SG

Control
FITC-LPS (5 µg ml-1)

2

G

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the enrichment of hemocyte subpopulations
[hyaline hemocytes (H1), semigranular hemocytes (SG2), and granular hemocytes (G3)] and the binding assays were performed as
described in Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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hemocyte population indicates that the granular cells that are able to bind the ligand have
been enriched about 3.5 times in the 60% discontinuous Percoll gradient portion that lay
near the bottom of the centrifuge tube. These results indicate the possible presence of a
LPS recognition system associated with a subpopulation of P. clarkii granular
hemocytes. This recognition system mediates the binding of these cells to LPS.
Table 11 shows the results obtained from a series of 3 experiments in which the
enriched hemocyte subpopulations and a mixed hemocyte population were presented
with MBSA-biotin followed by SFITC and with BSA conjugate followed by SFITC as
the control. No fluorescent cells above the level of autofluorescence were detected in the
control. The average percentage of fluorescent cells in the mixed hemocyte population
was 5.1%. The hyaline cells constituted the predominant hemocyte type of Band 1. The
0.1% of fluorescent cells obtained from this band consisted of hemocytes containing
cytoplasmic granules. These cells were somehow prevented from reaching the 50% or
60% discontinuous Percoll gradient interface or were introduced accidentally as
contaminants during the collection procedure. Band 2 consisted predominantly of
semigranular hemocytes. These cells displayed the typical fusiform morphology and
contained a variable number of small granules. The average 4.1% of fluorescent cells
detected in this band, following MBSA-biotin and SFITC presentation, also appeared to
consist of contaminating granular cells. Band 3 was composed of mostly granular and
some semigranular hemocytes. A comparison of the percentage of fluorescent cells
obtained from this band with that of the mixed hemocyte population, following MBSAbiotin and SFITC presentation, indicates that the granular cells that are able to bind the
ligand have been enriched about 4 times in the 60% discontinuous Percoll gradient
portion that lay near the bottom of the centrifuge tube.
Figure 4 graphically summarizes the results for the binding of the 2 ligands to
enriched subpopulations of hemocytes. It indicates the possible presence of 2 recognition
systems associated with a subpopulation of P. clarkii granular hemocytes, which mediate
the binding of LPS and mannose to these cells.
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Table 11. Binding of MBSA-Biotin and SFITC to Enriched Hemocytes of Procambarus clarkii
Treatment

Control (1 µg ml-1 BSA)
⇒
MBSA-biotin (1 µg ml-1)
Control (1 µg ml-1 BSA)
⇒
MBSA-biotin (1 µg ml-1)
Control (1 µg ml-1 BSA)
⇒
MBSA-biotin (1 µg ml-1)
Control (1 µg ml-1 BSA)
⇒
MBSA-biotin (1 µg ml-1)

Cell
Band

Mixed

1

2

3

%Fluorescent Cellsa

Predominant
Hemocyte
Type
Exp.1
1

2

3

nb

Exp.2

Exp.3

Avg.+S.E.M.

0

0

0

0

2272

4.1

6.4

4.9

5.1 + 0.67

2284

0

0

0

0

2975

0.04

0.1

0.2

0.1 + 0.05

3112

0

0

0

0

1223

1.0

4.8

6.6

4.1 + 1.65

1747

0

0

0

0

1536

15.2

19.8

23.7

19.6 + 2.46

1249

H ,SG ,G

H

SG

G

a

Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the enrichment of hemocyte subpopulations
[hyaline hemocytes (H1), semigranular hemocytes (SG2), and granular hemocytes (G3)] and the binding assays were performed as
described in Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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Figure 4. Enrichment of Procambarus clarkii Hemocyte Subpopulations Followed by
FITC-LPS and MBSA-Biotin + SFITC Binding.
The bars indicate the mean percent of fluorescent hemocytes observed in a mixed
hemocyte population, and in morphologically enriched but not pure hyaline,
semigranular, and granular hemocyte subpopulations, obtained from Band 1, Band 2, and
Band 3, respectively, of the discontinous Percoll gradient. The fluorescent hemocytes
that bound LPS (gray bars) and the MBSA-biotin conjugate (white bars), both conjugated
to fluorescent probes, appear to have been enriched about 3 to 4 times when compared to
the mean percent of fluorescent hemocytes observed in the mixed population.
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Double Immunolabeling of Procambarus clarkii Hemocytes with MBSA-Biotin, ARITC
and FITC-LPS and Laser Scanning Confocal Microscopy
To ascertain whether the LPS and mannose specific recognition systems are
present on the surface of similar or disparate subpopulations of granular hemocytes,
mixed cells were double immunolabeled by incubation for 30 minutes at a time with
MBSA-biotin, ARITC, and FITC-LPS. As a control, hemocytes were incubated with the
BSA conjugate and with 0.15M NaCl. No fluorescent cells above the level of
autofluorescence were detected in the control. The results in Table 12 indicate that an
average of 7.6% of fluorescent cells was detected. These cells were granular hemocytes
that displayed both green and red distinct granular fluorescence at 520 nm and 572 nm
emission wavelengths, respectively. Hemocytes that displayed only green or only red
fluorescence were not observed. These results indicate that the same subpopulation of
granular hemocytes binds to both LPS and mannose.
A Leica confocal laser scanning microscope was then used to obtain images of the
double immunolabeled cells from a mixed hemocyte population. The same double
immunolabeled hemocytes were studied in 2 ways: 1) by sequential excitation with an
Argon ion laser emitting at 488 nm to excite the FITC bound to LPS (Figure 5 A) and
with a HeNe laser emitting at 543 nm to excite the ARITC conjugated to MBSA-biotin
(Figure 5 B), and 2) by superposition of both individual images (Figure 5 C). The
superposition of the 2 images resulted in a combined 2-color FITC-ARITC image of the
hemocyte surface. Again, granular hemocytes appeared to display both green and red
fluorescence at 520 nm and 572 nm emission wavelengths, respectively. Hemocytes that
displayed only green or only red fluorescence were not observed. The images give
additional support to the specificity of the immunostaining. They show both the FITCLPS and the MBSA-biotin conjugated to ARITC bound to the surface of the same
granular hemocytes, possibly via 2 different and specific recognition systems (Figure 5).
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Table 12. Double Immunolabeling of Procambarus clarkii Hemocytes with MBSA-Biotin, ARITC and FITC-LPS
%Fluorescent Cellsa

Treatment

nb

Exp. 1

Exp. 2

Exp. 3

Avg.+S.E.M.

Control (1 µg ml-1 BSA +
5 µg ml-1 ARITC +
0.15M NaCl)

0

0

0

0

3247

MBSA-biotin (1 µg ml-1) + ARITC
(5 µg ml-1) + FITC-LPS (1 µg ml-1)

8.4

6.6

7.7

7.6 + 0.52

3056

a

Cells displaying both green and red distinct granular fluorescence at 520 nm and 572 nm wavelengths, respectively; the binding
assays were performed as described in Materials and Methods
b
n=average number of total cells counted per individual assay concentration
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A

B

C

Figure 5. Confocal Images of Procambarus clarkii Hemocytes Double Immunolabeled with Both MBSA-Biotin + ARITC and FITCLPS (A-C).
A 200x magnification was enlarged 8 times on the monitor, resulting in a total 1,600x magnification. (A) Image of granular cells in a
mixed hemocyte population after excitation with the 488 nm laser (520 nm emission wavelength), indicating the specific binding of
FITC-LPS to the hemocytes' surfaces. (B) Image of the same granular cells following excitation with the 543 nm laser (572 nm
emission wavelength), showing the presence of ARITC conjugated to MBSA-biotin labeled hemocytes. (C) Picture of the granular
hemocytes in (A) and (B) obtained by superimposing the previous 2 images of the same optical section. Because hemocytes that
displayed only pseudo-green or only pseudo-red fluorescence were not observed, this image shows the presence of both LPS and
mannose recognition systems on the surface of the same granular hemocytes.
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CHAPTER 4
DISCUSSION
As in mammalian systems, invertebrate pattern recognition molecules sample the
internal environment and have multiple functions that are responsible for the
interrelated host immune activities of specific recognition and response (1,2,3).
Although more primitive from an evolutionary perspective and devoid of antibody
producing ability, the recognition of “non-self” molecules in invertebrates appears to be
extremely efficient. The proPO system released by semigranular and granular cells,
following recognition by its endogenous proteins and their receptors, responds to
picograms per liter of bacterial LPS, peptidoglycans, and fungal β-1,3-glucans (32). In
this study, LPS and mannose binding and inhibition assays were coupled to the isolation
by buoyant density of morphologically enriched subpopulations of P. clarkii hemocytes,
in order to establish the possible presence and localization of LPS and mannose receptors
in this invertebrate species.
First of all, the results indicate that LPS and MBSA-biotin (a neoglycoprotein),
both conjugated to exogenous fluorescent probes, bind to a small percentage of
hemocytes. This percent ranges from about 6%-10% (Tables 1,2,3). The conjugation of
MBSA-biotin to streptavidin-fluorescein isothiocyanate and to avidin-rhodamine
isothiocyanate could not significantly alter the results, since streptavidin has been
reported to have a biotin-binding activity similar to that of avidin (37).
Having a definable ligand specificity is one of the preliminary standards that
suggests the presence of a receptor-mediated binding process (13). The inhibition assays
summarized in Figure 1 show that LPS concentrations of 10, 20, and 40 µg ml-1 caused
an approximately 73% reduction in the number of observed fluorescent cells when FITCLPS was presented to the hemocytes. Lower concentrations of the inhibitory ligand
resulted in a 38% inhibitory potency. These results indirectly indicate that LPS
effectively inhibits the binding of FITC-LPS to hemocytes.
The mannose receptor has been reported to bind to certain strains of LPS that
have nonreducing terminal N-acetyl-D-glucosamine and D-mannoheptose residues
present in their rough outer core polysaccharide (4,16). However, the LPS used in this
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study was purified from the smooth lipopolysaccharide of E. coli, serotype 0III:B4. The
polysaccharide side chains in the LPS from this organism do not contain mannose. They
have terminally located colitose residues that form the primary antigenic determinant of
the polymer and mask the N-acetyl-D-glucosamine residues of the molecule (38). As
expected, and as indicated in Table 5 and Figure 1, various concentrations of LPS did not
reduce the observed number of fluorescent cells when the hemocytes were presented with
MBSA-biotin and ARITC. These results indirectly indicate that LPS from E. coli,
serotype 0III:B4, was an ineffective antagonist for the binding of the MBSA-biotin
conjugate to hemocytes. They provide evidence for the LPS specificity of one of these
hemocyte recognition systems.
Mannan is the principal antigen of yeast (15), and it has been shown to have a
nearly complete inhibitory potency on the uptake of β-glucuronidase by macrophages
(12). However, it had no inhibitory activity on the binding to hemocytes of MBSA-biotin
subsequently conjugated to SFITC because the percentage of fluorescent hemocytes
remained constant (Table 7, Figure 2). It is possible that, due to steric hindrance, the
specific conformation of the purified mannan antigen could not be accommodated in
vitro by the mannose recognition system of hemocytes. Furthermore, it has been reported
that invertebrate lectins display a stronger affinity for glycoprotein sugars than for
polysaccharides (39).
Horseradish peroxidase is a glycoprotein, which contains an 86% carbohydrate
content that consists predominantly of mannose and glucosamine (14). In contrast to
mannan, horseradish peroxidase concentrations of 10, 25, 50, and 100 µg ml-1 achieved
an almost 60% decrease in the number of fluorescent hemocytes that bound MBSAbiotin and SFITC (Table 9). It had no effect on the number of fluorescent hemocytes that
bound FITC-LPS (Table 8). These results indirectly suggest that horseradish peroxidase
effectively inhibited the binding of MBSA-biotin to hemocytes (Figure 3). They provide
evidence for the possible mannose specificity of this hemocyte recognition system.
However, other carbohydrate moieties of horseradish peroxidase beside mannose could
have ligated to the hemocytes and prevented the binding of the MBSA-biotin conjugate.
The hemocyte subpopulations were morphologically enriched by buoyant density
(23,24) to ascertain which hemocyte subpopulation is responsible for binding to LPS and
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to MBSA-biotin (Tables 10 and 11, Figure 4). When compared to the other bands, the
highest percent of fluorescent cells (24% for FITC-LPS, and 20% for MBSA-biotin and
SFITC presentation) was found in Band 3. This band was present in the 60%
discontinuous Percoll gradient portion that lay near the bottom of the centrifuge tube, and
it predominantly contained granular hemocytes. In both sets of experiments, a
comparison of the percentage of fluorescent cells obtained from Band 3 with that of the
mixed hemocyte population indicates that the granular cells having the ability to bind the
ligands have been enriched about 3 to 4 times in Band 3. A subpopulation of granular
hemocytes is apparently capable of binding to LPS and mannose. The hyaline cells were
the predominant cells in Band 1. The extremely small percent of fluorescent cells
obtained from this band consisted entirely of hemocytes with cytoplasmic granules. Only
4% of the hemocytes in Band 2 fluoresced, indicating the possible contamination of this
band with granular hemocytes during the collection procedure.
The cytoplasm of many hemocytes in Bands 2 and 3 appeared lysed and damaged,
and autofluorescence derived from the granules was routinely observed in the control
during excitation at 490 nm wavelength. Thus, the main problem to be overcome when
counting fluorescent hemocytes was to differentiate between autofluorescence and
specific immunofluorescence. It is possible that the percentages of fluorescent
hemocytes obtained for these 2 bands are lower than they should be because only
hemocytes displaying intense green flourescence were considered positive.
To determine if similar or disparate granular hemocytes contain the LPS- and
mannose-specific recognition systems, mixed hemocytes were exposed for 30 minutes at
a time to MBSA-biotin, ARITC, and FITC-LPS (Table 12). One P. clarkii hemocyte
type, which seemed to have a round or slightly oval morphology and contained numerous
large cytoplasmic granules, fluoresced both red and green when observed under
fluorescence and confocal microscopy (Figure 5 A and B). Both fluorescent probes were
visible on the surface of these particular hemocytes (Figure 5 C). Hemocytes that
displayed only green or only red fluorescence were not observed, suggesting that this
hemocyte subpopulation contains both the LPS and the mannose receptors on their
surfaces.
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Previous reports suggest that granular hemocytes, unlike semigranular hemocytes,
are unable to degranulate in response to direct exposure to LPS and fungal cell wall
molecules (1,17,28). However, the preliminary evidence presented in this study points to
the possible presence of 2 recognition systems associated with a subpopulation of
granular hemocytes from the red swamp crayfish, P. clarkii. These receptors specifically
bind to both LPS and mannose, and they may be involved in triggering vital cellular and
humoral defense mechanisms of this animal in response to a pathogenic challenge. The
isolation and purification, as well as the details of in vivo function, ligand interaction and
cell-to-cell communication of these 2 invertebrate specific recognition systems await
further investigation.
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APPENDIX
List of Formulas
Crayfish Anticoagulant Buffer (23)
0.14 M NaCl
0.1 M Glucose
30 mM Trisodium Citrate
26 mM Citric Acid
10 mM EDTA
pH = 4.6
Dissolved in double distilled H2O and filter sterilized
TNM-FH Insect Medium
Powdered cell culture medium dissolved to 51.2 mg ml-1 in sterile double distilled H2O
and filter sterilized
Crayfish Saline (24)
0.2 M NaCl
5.4 mM KCl
10 mM CaCl2
2.6 mM MgCl2
2 mM NaHCO3
pH 6.8
Dissolved in double distilled H2O and autoclaved
NaCl
0.15 M NaCl made up in sterile double distilled H2O and autoclaved
Glycine Saline Buffer (Immunofluorescence Mounting Medium) (36)
14.0 g Glycine
0.7 g NaOH
17 g NaCl
1 g Sodium azide
Dissolved in 500 ml double distilled H2O, and made up to 1000 ml
pH 8.6
30 ml buffer mixed with 70 ml glycerol (30%)
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